Life span and thrombotic prevalence insphDem/sphDem versussph/sph mice
Genotype . | Neonates surviving to wean (%) . | Neonates with thrombi4-150 (%) . | Average life span of weaned mice (m) . | Adults4-151 with cardiac thrombi (%) . |
---|---|---|---|---|
sphDem/sphDem | 32 (n = 120) | 69 (n = 16) | 2.5 (n = 65) | 95 (n = 21) |
sph/sph | 70 (n = 130) | 0 (n = 23) | 6.7 (n = 60) | 100 (n = 45) |
Genotype . | Neonates surviving to wean (%) . | Neonates with thrombi4-150 (%) . | Average life span of weaned mice (m) . | Adults4-151 with cardiac thrombi (%) . |
---|---|---|---|---|
sphDem/sphDem | 32 (n = 120) | 69 (n = 16) | 2.5 (n = 65) | 95 (n = 21) |
sph/sph | 70 (n = 130) | 0 (n = 23) | 6.7 (n = 60) | 100 (n = 45) |